Last updated on July 2019

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Crohn's Disease
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Have moderate or severe active CD
  2. Have inadequate response to existing therapies

Exclusion Criteria:

Patients with any contraindication for vedolizumab

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.